The crucial roles of inflammatory mediators in inflammation: A review.
Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. · 2018
Read The crucial roles of inflammatory mediators in inflammation: A review. by Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5993766.txt.
Introduction
Abdulkhaleq and co-authors review the crucial roles of inflammatory mediators in inflammation. Their review appeared in Veterinary World. Inflammation is the tissue response to harmful invaders and injury. Cells such as macrophages, neutrophils, and lymphocytes drive it. They release a suite of specialised substances. These include vasoactive amines, eicosanoids, and pro-inflammatory cytokines. Acute-phase proteins also join the response. Together they limit damage and start healing.
The review explains how these mediators run the process. It covers the cells that release them in turn. Natural anti-inflammatory agents get a brief look as well. The authors stress that grasping this machinery unlocks better therapies.
Catalog record
| CREATOR | Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The crucial roles of inflammatory mediators in inflammation: A review By L. A. Abdulkhaleq, M. A. Assi, Rasedee Abdullah, M. Zamri-Saad, Y. H. Taufiq-Yap, M. N. M. Hezmee Published in: Veterinary World DOI: 10.14202/vetworld.2018.627-635 ABSTRACT The inflammatory response is a crucial aspect of the tissues’ responses to deleterious inflammogens. This complex response involves leukocytes cells such as macrophages, neutrophils, and lymphocytes, also known as inflammatory cells. In response to the inflammatory process, these cells release specialized substances which include vasoactive amines and peptides, eicosanoids, proinflammatory cytokines, and acute-phase proteins, which mediate the inflammatory process by preventing further tissue damage and ultimately resulting in healing and restoration of tissue function. This review discusses the role of the inflammatory cells as well as their by-products in the mediation of inflammatory process. A brief insight into the role of natural anti-inflammatory agents is also discussed. The significance of this study is to explore further and understand the potential mechanism of inflammatory processes to take full advantage of vast and advanced anti-inflammatory therapies. This review aimed to reemphasize the importance on the knowledge of inflammatory processes with the addition of newest and current issues pertaining to this phenomenon. INTRODUCTION The inflammation term is taken from the Latin word “inflammare” (to burn) (de oliveira). Inflammation is one of the most central processes required in defense of animal cells against certain injuries or microbial infections [1,2]. Nevertheless, inflammation regularly progresses to acute [3] or chronically [1]. Chronic inflammation is caused due to a variety of diseases including neurodegenerative disorders, cancer, and cardiovascular diseases [4]. Mechanism of inflammation represents a chain of organized, dynamic responses including both cellular and vascular events with specific humoral secretions. These pathways involve changing physical location of white blood cells (monocytes, basophils, eosinophils, and neutrophils), plasma, and fluids at inflamed site [5]. A group of secreted mediators and other signaling molecules (e.g., histamine, prostaglandins, leukotrienes, oxygen- and nitrogen-derived free radicals, and serotonin) are released by immune defense cells principally in the mechanism which can contribute in the event of inflammation [6]. Whatever, the inflammatory response is triggered through two phases: (a) acute and (b) chronic, and each is apparently mediated by a different mechanism [3]. These immune responses which involved in acute inflammation can be divided into vascular and cellular [7]. The responses which occur in microvasculature normally appear in few minutes following tissue injury or microbial infection in the presence of other inflammatory stimuli named vascular events [7]. The occurrence of these processes is rapid and eventually will lead to vasodilation and subsequently makes the vessels become more permeable. This processes will result in entry of inflammatory mediators and produces interstitial edema [8]. Inflitration of white blood cells from circulatory system is essential during inflammatory responses [9,10]. A group of chemotactic agents such as microbial endotoxins holding amino terminal N-formyl methionyl groups, C5a complement fragment, and interleukins along with the secretions of basophils such as platelets activating factor, histamine, and leukotriene B can stimulate intense leukocytes infiltration within few minutes [11,12]. Among the leukocytes, neutrophils are the first inflammatory cells that are recruited at the acute inflammation site [13]. Infiltration of immune cells triggered via a complicated mechanism in which white blood cells work together with endothelium in postcapillary venules [14]. Cellular events encompass the successive capture, trundling, and firming an adhesion to the microvascular endothelium [15]. These events in the mobilization pathway are arranged by cell adhesion molecules (CAMs). These CAMs include intracellular adhesion molecules (ICAM)-1, ICAM-2, integrins, and selectin. The selectin group of CAM contains three families; P-selectin and E-selectin produced by endothelial cells and L-selectin produced by white blood cells [16]. The adhesion of high affinity presented on white blood cells in the endothelium is mediated by the interaction between integrins (CDII/CDI8), and adhesion molecules (CAM-l and CAM-2) expressed on white blood cells and endothelium cells, respectively [17]. Following a period of stationary adhesion, the white blood cells may leave the postcapillary venules extending pseudopodia between endothelial cells and reach into the subendothelial space. This complex event is often referred as white blood cell extravasations and transendothelial migration [18]. The inflammation of chronic events are distinguished by mononuclear cell infiltration (e.g., monocyte and lymphocytes), fibroblasts proliferation, collagen fibers, and connective tissue formation, which ultimately result in 2-mm granuloma [19]. With chronic inflammation, the tissue degeneration is normally mediated by nitrogen species, proteases, and other reactive oxygen species released from infiltrated inflammatory cells [20]. Certainly, genomic alterations in p53 were approved as causes for many chronic inflammatory diseases (e.g., inflammatory bowel diseases and rheumatoid arthritis) in addition to cancers [21-23]. The novelty of this review is that it provides the summary of the latest accumulation of knowledge about the involvement of mediators in inflammation while untangling some misconception and argument regarding the inflammatory processes. This review aimed to reemphasize the importance of the knowledge of inflammatory processes with the addition of newest and current issues about this phenomenon. MEDIATORS A variety of chemical mediators from circulation system, inflammatory cells, and injured tissue actively contribute to and adjust the inflammatory response [24]. The released chemical mediators include (1) vasoactive amines such as histamine and serotonin, (2) peptide (e.g., bradykinin), and (3) eicosanoids (e.g., thromboxanes, leukotrienes, and prostaglandins). VASOACTIVE AMINES AND PEPTIDE Histamine is released in a quantity of few pictograms from basophils to maintain acute-phase response during inflammation events [25]. Serotonin is produced via decarboxylation of tryptophan, and it is stored in the granule [26]. In murine, the serotonin is available in basophilic granules, while in humans, it is present in platelets. Four serotonin receptors, namely 5-HTl, 5-HT2, 5-HT3, and 5-HT4, were documented to mediate its biological functions [27]. Bradykinin is a nanopeptide created from plasma Kinin–Kallikrein system [28]. Two or more distinct receptors are present for bradykinins which have been titled B1 and B2 [29]. Similar to histamine and serotonin, it can increase the synthesis of prostaglandins and produces pain locally [30]. EICOSANOIDS Arachidonic acid, which represents the main component of membrane phospholipids in all the cells, is one of the most important substrates in the synthesis of biologically active mediators of the inflammation called eicosanoids [31]. The latter includes the products of 5-lipoxygenase (leukotriene and 5-hydroxyeicosatetraenoic acid), cyclooxygenases (prostaglandins and thromboxanes), and 12-1ipoxygenase (12-hydroxyeicosatetraenoic acid) [32,33]. The 5-lipoxygenase enzyme was discovered in 1976 from glycogen-elicited rabbit polymorphonuclear leukocytes [34]. The production of 5-LOX protein is mainly created in the immune cells of myeloid origin: (1) mononuclear cells such as rhogocytes, necrophages, and lymphocytes [35] and (2) polymorphonuclear leukocytes such as neutrophils and eosinophils [36]. These cells display a vital role in immune responses inflammatory reactions. However, erythrocytes, platelets, endothelial cells, and T-cell are 5-LOX negative [37]. Cyclooxygenase is an enzyme involved in the synthesis of proteinoids including potent proinflammatory prostaglandins and metabolism of arachidonic acid, which exists in at least two isoforms: cyclooxygenase-1 and -2 [38]. Cyclooxygenase-1 is produced constitutively in most of the mammal cell types and platelets. It is also secreted in vascular endothelium, stomach, forebrain, uterine epithelium, and kidney. On the other hand, cyclooxygenase-1 (not only cyclooxygenase-2) has a pathological role in the animal body, and it can also be stimulated at the site of inflammation [39]. These findings have been further supported by different